Clinical trials
Clinical Study clinical trials
Below are recruiting clinical study clinical trials, each written for real people, not researchers. We’re tracking 1,742 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07052253RecruitingPhase 2
Combination therapy for advanced liver cancer
This trial tests two experimental drugs (AK104 and AK112) combined with an oral tablet (TT-00420) for people with advanced hepatocellular carcinoma (a type of liver cancer) who have not had previous systemic treatment. The goal is to see if this combination can shrink tumors or slow cancer growth.
Wuhan, ChinaAges 18–75 - NCT07047183RecruitingPhase 2
A study of venetoclax and azacitidine before stem cell transplant for MDS
This trial tests a combination of two drugs (venetoclax and azacitidine) given before a stem cell transplant to see if it improves outcomes for people with a certain type of myelodysplastic syndromes (MDS) that is higher risk. If you have higher-risk MDS and are planning a stem cell transplant, this may be an option.
Changchun, JilinAges 18 years+ - NCT07047560RecruitingPhase 2
A new chemo combo for advanced colorectal cancer
This trial tests a different way of giving a chemotherapy drug called irinotecan, along with two other drugs (5-FU and bevacizumab), for people whose cancer got worse after first-line treatment. It aims to see if this combination can help control the cancer.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07054463Recruiting
Fu's needling for healing wrist fractures
This study tests whether adding Fu's subcutaneous needling (a special needle technique) to standard care (splinting after a bone realignment) helps heal wrist fractures faster. It's for adults who recently broke their wrist and have already had the bone set without surgery.
Guangzhou, GuangdongAges 18–85 - NCT07053670RecruitingPhase 1
Study of CT1190B for relapsed or refractory B-cell lymphoma
This study tests a new cancer treatment called CT1190B for people with certain types of B-cell lymphoma that have not responded to or came back after other treatments. The goal is to see if it can help shrink or control the lymphoma.
Wuhang, HubeiAges 18–75 - NCT07053605Recruiting
Laparoscopic splenic artery aneurysm repair, spleen saved
This study tests a keyhole surgery (laparoscopy) to remove an aneurysm from the splenic artery while saving your spleen. It may help people with larger, growing, or ruptured splenic artery aneurysms.
Yangzhou, JiangsuAges 18 years+ - NCT07051980RecruitingPhase 2
Oxygen through a tube above the voice box for sedated ERCP
This study tests a new way to deliver oxygen during a sedated ERCP, using a thin tube placed above the voice box instead of a breathing tube. It aims to see if this method is safe and practical for people having this procedure.
Hangzhou, ZhejiangAges 18 years+ - NCT07044921RecruitingPhase 2
Irinotecan liposome combination for advanced colorectal cancer
This trial tests a new combination treatment for people with advanced colorectal cancer whose cancer has stopped responding to irinotecan. The goal is to see if adding a liposome form of irinotecan to other drugs can help shrink tumors or slow the disease.
BeijingAges 18 years+ - NCT07043725RecruitingPhase 3
Neoadjuvant TQB2102 for HER2-positive breast cancer
This trial tests a new drug called TQB2102 given before surgery for HER2-positive breast cancer. The goal is to see if it can shrink the tumor enough to allow a successful surgery.
Bengbu, AnhuiAges 18–75 - NCT07036250RecruitingPhase 1/Phase 2
Study of U32 for acute myeloid leukemia
This trial tests a new treatment called U32 for people with acute myeloid leukemia (AML) that has come back or not responded to prior therapy. It aims to see if targeting certain proteins on leukemia cells can help control the disease.
SuzhouAges 2–65 - NCT06982807Recruiting
SMILE laser for stable nearsightedness
This study tests a new laser correction method called SMILE 4.0-VISULYZE to treat nearsightedness and other refractive errors. It may help people who are tired of glasses or contact lenses and want a quick, low-pain vision fix.
Nantong, JiangsuAges 18–40 - NCT07037238RecruitingPhase 2
Everolimus for treating vascular malformations
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
BeijingAges 18–65 - NCT07040228RecruitingPhase 1/Phase 2
Study of regorafenib, toripalimab, and chemo for advanced pancreatic cancer
This trial tests a combination of three drugs (regorafenib, toripalimab, and albumin-bound paclitaxel) as a third-line treatment for advanced pancreatic cancer that has progressed after two prior therapies. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Shenzhen, GuangdongAges 18–80 - NCT07041905Recruiting
Comparing two ways to treat deep cavities in back teeth
This study compares two ways of removing deep tooth decay to see which keeps the tooth nerve healthy and causes less pain afterward. It's for people who have two deep cavities on opposite sides of their mouth and want to help find the best treatment.
AdanaAges 15–55 - NCT07043322RecruitingPhase 2
Cabergoline vs coasting for OHSS prevention
This study tests whether a medicine called cabergoline can lower the chance of ovarian hyperstimulation syndrome (OHSS) in women undergoing IVF who are at high risk. It compares cabergoline with a standard technique called 'coasting' (stopping fertility drugs for a few days).
Damietta, New DamiettaAges 20–35 - NCT07039097Recruiting
Surgery for uterine septum to improve natural pregnancy
This trial tests if removing a uterine septum (a wall-like tissue inside the womb) through a minimally invasive procedure helps women who have not had repeated miscarriages get pregnant naturally. You would be randomly assigned to have the surgery or not, and your pregnancy outcomes would be tracked.
Changsha, HunanAges 20–40 - NCT04898647Recruiting
Study of blood thickness in Waldenström’s disease
This study looks at “hyperviscosity,” meaning very thick blood, in people with Waldenström macroglobulinemia (WM). Your results may help doctors better understand who needs treatment and what tests should be used, even if thick blood is not found.
AmiensAges 18 years+ - NCT07025304Recruiting
Study of REFLEX ULTRA 45 for nasal turbinate reduction in China
This trial tests a new device called REFLEX ULTRA 45 that uses radiofrequency energy to shrink the nasal turbinates (the fleshy shelves inside your nose) to help you breathe easier. It is for people with long-term nasal stuffiness who have not gotten relief from nasal sprays.
Guangzhou, GuangdongAges 18–65 - NCT07032688RecruitingPhase 1
Study of SHR-3167 for type 2 diabetes
This trial tests an experimental drug called SHR-3167 in people with type 2 diabetes. The goal is to see how the drug works in the body and how it affects blood sugar. It may be an option for adults who have had diabetes for at least 6 months.
Chengdu, SichuanAges 18–59 - NCT07033013Recruiting
Study of an oral supplement for menopause hot flashes
This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.
San Francisco, CaliforniaAges 40–65 - NCT07033494RecruitingPhase 2
Study of MK-2214 for early Alzheimer's disease
This trial tests an experimental medicine called MK-2214 for people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow memory and thinking problems.
Irvine, CaliforniaAges 50–85 - NCT07030790RecruitingPhase 1
Single dose study of KLA480 in healthy volunteers
This trial tests a single dose of KLA480 in healthy adults to see how the body processes it. It may help researchers understand the drug's safety and potential benefits.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07030712RecruitingPhase 1
Study of MK-8294 for advanced solid tumors
This trial tests an experimental drug called MK-8294 for people with advanced solid tumors that have stopped responding to standard treatments. It may be an option if you have certain types of cancer and are looking for a new treatment.
Chicago, IllinoisAges 18 years+ - NCT07022288Recruiting
Study of La Roche-Posay cream for mild facial eczema
This study tests whether a specific soothing moisturizer (La Roche-Posay B5 cream) helps people with mild, stable facial eczema. It is a simple, low-risk trial using a cream you can apply at home.
Shanghai, Shanghai MunicipalityAges 18–65
Hear when a new Clinical Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical study?
- Yes. Clin2 currently lists 1,742 recruiting clinical study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.